PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE

Compare PRAMIPEXOLE DIHYDROCHLORIDE (Pramipexole dihydrochloride) and RASAGILINE MESYLATE (Rasagiline) — clinical data, side effects, and patient experiences.

PRAMIPEXOLE DIHYDROCHLORIDE

Pramipexole dihydrochloride, Mirapex · Parkinson's Agent

How it works

12.1 Mechanism of Action Pramipexole is a non-ergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D 2 subfamily of dopamine receptors,...

Approved for

See full prescribing information

OralTablet

RASAGILINE MESYLATE

Rasagiline · Parkinson's Agent

How it works

12.1 Mechanism of Action Rasagiline is a selective, irreversible MAO-B inhibitor indicated for the treatment of idiopathic Parkinson’s disease. The results of a clinical trial desi...

Approved for

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline

a monoamine oxidase (MAO)-B inhibitor (MAOI)

is indicated for the treatment of Parkinson’s disease (1)

OralTablet

Quick Comparison

PRAMIPEXOLE DIHYDROCHLORIDERASAGILINE MESYLATE

Drug Class

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

PRAMIPEXOLE DIHYDROCHLORIDE

Drug Not Working

>10%

Fatigue

1-10%

Falls

1-10%

Nausea

1-10%

Condition Worsened

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

RASAGILINE MESYLATE

Falls

>10%

Drug Not Working

1-10%

Tremor

1-10%

Dizziness

1-10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Constipation

0.1-1%

FDA Warnings

PRAMIPEXOLE DIHYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS Falling Asleep During Activities of Daily Living: Sudden onset of sleep may occur without warning; advise patients to report symptoms
3) Hallucinations and Psychotic-like Behavior: May occur; risk increases with age
Although many of these patients reported somnolence while on pramipexole tablets, some perceived that they had no warning signs (sleep attack) such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with pramipexole dihydrochloride extended-release tablets, advise patients of the potential to develop drowsiness, and specifically ask about factors that may increase the risk for somnolence such as the use of concomitant sedating medications or alcohol, the presence of sleep disorders, and concomitant medications that increase pramipexole plasma levels (e

RASAGILINE MESYLATE

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5
When used as an adjunct to levodopa (Studies 3 and 4), the risk for developing post-treatment high blood pressure (e
Rasagiline is contraindicated for use with meperidine, tramadol, methadone, propoxyphene, and MAO inhibitors (MAOIs), including other selective MAO-B inhibitors [see Contraindications ( 4 ) and Drug Interactions ( 7
Serotonin syndrome can result in death

Clinical Trial Data

No head-to-head clinical studies found for PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE.

PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE: What You Should Know

Key Differences

Both PRAMIPEXOLE DIHYDROCHLORIDE and RASAGILINE MESYLATE belong to the Parkinson's Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients.

Safety Considerations

PRAMIPEXOLE DIHYDROCHLORIDE carries 4 FDA warnings. RASAGILINE MESYLATE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

ENTACAPONE vs PRAMIPEXOLE DIHYDROCHLORIDE→PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE→PRAMIPEXOLE DIHYDROCHLORIDE vs ROPINIROLE HYDROCHLORIDE→CARBIDOPA AND LEVODOPA vs PRAMIPEXOLE DIHYDROCHLORIDE→LEVODOPA vs PRAMIPEXOLE DIHYDROCHLORIDE→PRAMIPEXOLE DIHYDROCHLORIDE vs ROPINIROLE→

Loading comparison data...

PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE

Compare PRAMIPEXOLE DIHYDROCHLORIDE (Pramipexole dihydrochloride) and RASAGILINE MESYLATE (Rasagiline) — clinical data, side effects, and patient experiences.

PRAMIPEXOLE DIHYDROCHLORIDE

Pramipexole dihydrochloride, Mirapex · Parkinson's Agent

How it works

12.1 Mechanism of Action Pramipexole is a non-ergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D 2 subfamily of dopamine receptors,...

Approved for

See full prescribing information

OralTablet

RASAGILINE MESYLATE

Rasagiline · Parkinson's Agent

How it works

12.1 Mechanism of Action Rasagiline is a selective, irreversible MAO-B inhibitor indicated for the treatment of idiopathic Parkinson’s disease. The results of a clinical trial desi...

Approved for

1 INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson’s disease (PD). Rasagiline

a monoamine oxidase (MAO)-B inhibitor (MAOI)

is indicated for the treatment of Parkinson’s disease (1)

OralTablet

Quick Comparison

PRAMIPEXOLE DIHYDROCHLORIDERASAGILINE MESYLATE

Drug Class

Parkinson's Agent

Route

Oral

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

PRAMIPEXOLE DIHYDROCHLORIDE

Drug Not Working

>10%

Fatigue

1-10%

Falls

1-10%

Nausea

1-10%

Condition Worsened

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

RASAGILINE MESYLATE

Falls

>10%

Drug Not Working

1-10%

Tremor

1-10%

Dizziness

1-10%

Drowsiness

1-10%

Nausea

1-10%

Fatigue

1-10%

Constipation

0.1-1%

FDA Warnings

PRAMIPEXOLE DIHYDROCHLORIDE

5 WARNINGS AND PRECAUTIONS Falling Asleep During Activities of Daily Living: Sudden onset of sleep may occur without warning; advise patients to report symptoms
3) Hallucinations and Psychotic-like Behavior: May occur; risk increases with age
Although many of these patients reported somnolence while on pramipexole tablets, some perceived that they had no warning signs (sleep attack) such as excessive drowsiness, and believed that they were alert immediately prior to the event
Before initiating treatment with pramipexole dihydrochloride extended-release tablets, advise patients of the potential to develop drowsiness, and specifically ask about factors that may increase the risk for somnolence such as the use of concomitant sedating medications or alcohol, the presence of sleep disorders, and concomitant medications that increase pramipexole plasma levels (e

RASAGILINE MESYLATE

5 WARNINGS AND PRECAUTIONS May cause hypertension (including severe hypertensive syndromes) at recommended doses ( 5
When used as an adjunct to levodopa (Studies 3 and 4), the risk for developing post-treatment high blood pressure (e
Rasagiline is contraindicated for use with meperidine, tramadol, methadone, propoxyphene, and MAO inhibitors (MAOIs), including other selective MAO-B inhibitors [see Contraindications ( 4 ) and Drug Interactions ( 7
Serotonin syndrome can result in death

Clinical Trial Data

No head-to-head clinical studies found for PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE.

PRAMIPEXOLE DIHYDROCHLORIDE vs RASAGILINE MESYLATE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.